Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Separation or purification
Reexamination Certificate
2001-09-26
2004-09-28
Saunders, David (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Separation or purification
C436S547000, C436S548000, C436S824000, C436S828000, C530S388850, C530S389700
Reexamination Certificate
active
06797814
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates generally to protein purification. In particular, the invention relates to a method for purifying C
H
2/C
H
3 region-containing proteins, such as antibodies and immunoadhesins, by Protein A affinity chromatography.
2. Description of Related Art
The large-scale, economic purification of proteins is increasingly an important problem for the biotechnology industry. Generally, proteins are produced by cell culture, using either mammalian or bacterial cell lines engineered to produce the protein of interest by insertion of a recombinant plasmid containing the gene for that protein. Since the cell lines used are living organisms, they must be fed with a complex growth medium, containing sugars, amino acids, and growth factors, usually supplied from preparations of animal serum. Separation of the desired protein from the mixture of compounds fed to the cells and from the by-products of the cells themselves to a purity sufficient for use as a human therapeutic poses a formidable challenge.
Procedures for purification of proteins from cell debris initially depend on the site of expression of the protein. Some proteins can be caused to be secreted directly from the cell into the surrounding growth media; others are made intracellularly. For the latter proteins, the first step of a purification process involves lysis of the cell, which can be done by a variety of methods, including mechanical shear, osmotic shock, or enzymatic treatments. Such disruption releases the entire contents of the cell into the homogenate, and in addition produces subcellular fragments that are difficult to remove due to their small size. These are generally removed by differential centrifugation or by filtration. The same problem arises, although on a smaller scale, with directly secreted proteins due to the natural death of cells and release of intracellular host cell proteins in the course of the protein production run.
Once a clarified solution containing the protein of interest has been obtained, its separation from the other proteins produced by the cell is usually attempted using a combination of different chromatography techniques. These techniques separate mixtures of proteins on the basis of their charge, degree of hydrophobicity, or size. Several different chromatography resins are available for each of these techniques, allowing accurate tailoring of the purification scheme to the particular protein involved. The essence of each of these separation methods is that proteins can be caused either to move at different rates down a long column, achieving a physical separation that increases as they pass further down the column, or to adhere selectively to the separation medium, being then differentially eluted by different solvents. In some cases, the desired protein is separated from impurities when the impurities specifically adhere to the column, and the protein of interest does riot, that is, the protein of interest is present in the “flow-through.”
Affinity chromatography, which exploits a specific interaction between the protein to be purified and an immobilized capture agent, may also be an option for some proteins. Protein A is a useful adsorbent for affinity chromatography of proteins, such as antibodies, which contain an Fc region. Protein A is a 41 kD cell wall protein from
Staphylococcus aureas
which binds with a high affinity (about 10
−8
M to human IgG) to the Fc region of antibodies.
SUMMARY OF THE INVENTION
A problem associated with Protein A chromatography of contaminated protein preparations has been identified herein. In particular, it has been observed that in Protein A chromatography using a glass or silica surface for adsorbing the Protein A (e.g. where the Protein A is immobilized on a controlled pore glass column or a silicic acid column), contaminants in the protein preparation (such as Chinese Hamster Ovary proteins (CHOP), where the protein preparation is derived from a CHO cell) adhere to the glass or silica surface of the solid phase. This was found to occur even when the solid phase is coated with a reagent (such as glycerol) in an attempt to prevent nonspecific adherence thereto. An intermediate wash step has been devised herein which addresses this problem. This wash step serves to remove the contaminants, but not the immobilized Protein A or the protein of interest bound to the Protein A, from the solid phase. In particular, it has been found that hydrophobic electrolytes, e.g., tetramethylammonium chloride (TMAC) and tetraethylammonium chloride (TEAC), can be used in this intermediate wash step.
Accordingly, the invention provides a method for purifying a protein, which comprises a C
H
2/C
H
3 region, from a contaminated solution thereof by Protein A chromatography comprising the following steps performed sequentially: (a) adsorbing the protein to Protein A immobilized on a solid phase comprising silica or glass; (b) removing contaminants bound to the solid phase by washing the solid phase with a hydrophobic electrolyte solvent; and (c) recovering the protein from the solid phase.
In preferred embodiments, the protein is an antibody (e.g. an anti-HER2, anti-IgE or anti-CD20 antibody) or an immunoadhesin (e.g. a TNF receptor immunoadhesin).
REFERENCES:
patent: 5200471 (1993-04-01), Coleman et al.
patent: 5429746 (1995-07-01), Shadle et al.
patent: 5451660 (1995-09-01), Builder et al.
patent: 5731168 (1998-03-01), Carter et al.
patent: 6127526 (2000-10-01), Blank
patent: 6333398 (2001-12-01), Blank
patent: 3627063 (1988-02-01), None
patent: 263934 (1988-04-01), None
patent: 323027 (1989-07-01), None
patent: 5262799 (1993-10-01), None
patent: WO 94/07912 (1994-04-01), None
Carter, P. et al., “Humanization of an anti-p185HER2antibody for human cancer therapy”Proc. Natl. Acad. Sci.89:4285-4289 (1992).
Chamow et al., “A Humanized, Bispecific Immunoadhesin-Antibody That Retargets CD3+Effectors to Kill HIV-1-Infected Cells”Journal of Immunology153:4268-4280 (1994).
Dean, John A.Lange's Handbook of Chemistry, 13th edition, New York:McGraw-Hill Book Company pps. 7-627 and 7-634 (1986).
Mark et al., “Expression and Characterization of Hepatocyte Growth Factor Receptor-IgG Fusion Proteins”The Journal of Biological Chemistry267(36):26166-26171 (Dec. 25, 1992).
Sulkowski, E., “Controlled Pore Glass Chromatography of Proteins”Protein Purification: Micro to Macro: proceedings of a Cetus-UCLA symposium(Frisco, Colorado, Mar. 20-Apr. 4, 1987), Richard Burgess, New York:A.R. Liss vol. 68:177-195 (1987).
Tanford, CharlesThe Hydrophobic Effect: Formation of Micelles and Biological Membranes, New York:John Wiley & Sons pps. 1 (1980).
Genentech Inc.
Lee Wendy M.
Saunders David
LandOfFree
Protein purification does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protein purification, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein purification will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3231700